- Report
- July 2024
- 189 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- July 2024
- 185 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- June 2024
- 182 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 182 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 185 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 186 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 184 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 185 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 182 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 183 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 182 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 182 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- May 2024
- 185 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- April 2025
- 124 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2025
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2025
- 114 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- April 2025
- 110 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- July 2024
- 100 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- July 2024
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Drug Pipelines
- April 2025
- 450 Pages
Global
From €4580EUR$5,000USD£3,893GBP

Cell therapy is a type of biotechnology that involves the use of living cells to treat or prevent a disease. It is a rapidly growing field of medicine that has the potential to revolutionize the way diseases are treated. Cell therapy involves the use of living cells, either from the patient or from a donor, to replace or repair damaged cells or tissues. This can be done through the use of stem cells, gene therapy, or other cell-based therapies. Cell therapy has the potential to treat a wide range of diseases, including cancer, heart disease, diabetes, and neurological disorders.
Cell therapy is a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Novartis, Celgene, and Kite Pharma are leading the way in developing cell therapies for a variety of diseases. Other companies such as Gilead Sciences, Juno Therapeutics, and Bluebird Bio are also investing in cell therapy research and development. These companies are working to develop treatments that can improve the quality of life for patients with a variety of diseases. Show Less Read more